Search Videos and More
Updates: Colon Cancer Screening
This short video, brought to you by Minhhuyen T. Nguyen, MD, AGAF, FACP, Professor in the Department of Medicine and Director of Clinical Gastroenterology at Fox Chase, discusses what's new in colorectal cancer screening—from lowering the age of screening, to the efficacy of screening tests, to new techniques to improve colonoscopy.Innovative Approaches Needed to Move the Needle on Pancreatic Cancer
Two studies are testing whether the stroma can be used to the patient’s advantage.Two New Targeted Therapies Available for Advanced Cervical Cancer
Until late 2021, patients with recurrent cervical cancer had limited options for treatment. Available treatments included standard chemotherapy regimens and the VEGF-inhibitor bevacizumab.Study Finds COVID-19 Vaccines Using mRNA Technology Safe for People with Cancer
According to a new study from researchers at Fox Chase, mRNA vaccine for COVID-19 is just as safe for people with cancer as it is for cancer-free individuals.Fox Chase Cancer Center
Department of SurgicalL Oncology
Division of General Surgery
Highlights 2021
Christine Amoroso Coordinates Treatment-Optimizing, Dedicated Intravesical Clinic
Amoroso is part of the nurse-led dedicated intravesical clinic that helps optimize treatment for patients and workflow for other physicians and nurses.New Prognostic Model More Accurately Predicts Kidney Cancer Recurrence and Survival
Researchers at Fox Chase Cancer Center have developed a model that predicts disease recurrence and survival in patients with intermediate- and high-risk localized kidney cancer more accurately than existing prognostic models.Kutikov Leads International Effort to Optimize Management of Adrenal Masses
Fox Chase’s Alexander Kutikov, MD, FACS, is leading an international effort to create a centralized, streamlined, point-of-care resource for the management of adrenal masses.Molecular Profiling Named Top Advance of 2021 by ASCO
An American Society of Clinical Oncology (ASCO) collaborative report named the use of molecular profiling the top advance of 2021, but also identified priority areas for future research.Retroperitoneoscopic Robot-Assisted Partial Nephrectomy on Morbidly Obese Patient with Tumor in the Upper Pole
Benjamin T. Ristau, MD, MHA, Randall A. Lee, MD, and Alexander Kutikov, MD, FACS, present a retroperitoneoscopic robot-assisted partial nephrectomy on a morbidly obese patient.